5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin ụlọ ọrụ etiti.

Nkọwa dị mkpirikpi:

Aha: 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane

Ụdị okwu: 4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene

CAS: 461432-23-5

Dị ọcha: ≥99.0% (HPLC)

Ọdịdị: White to Pael Yellow Crystalline Powder

Ọkara nke Dapagliflozin (CAS: 461432-26-8) na ọgwụgwọ ụdị ọrịa shuga II.

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye na-emepụta ihe, ịdị ọcha dị elu, mmepụta azụmahịa
Dapagliflozin (CAS: 461432-26-8) Ndị na-emekọrịta ihe:
5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Njirimara kemịkalụ:

Aha Chemical 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
Ụdị okwu 4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene;4- (5-Brom-2-Chlorbenzyl) phenyl-Ethylether;Dapagliflozin Bromo adịghị ọcha
Nọmba CAS 461432-23-5
Nọmba CAT RF-PI447
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C15H14BrClO
Ibu molekụla 325.63
Ebe Na-agbaze 41.0 ruo 43.0 ℃
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ọcha ka Pael Yellow Crystalline ntụ ntụ
Ụzọ ịdị ọcha / nyocha ≥99.0% (HPLC)
Mmiri (KF) ≤0.50%
Mgbakọta adịghị ọcha ≤1.0%
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ọkara nke Dapagliflozin (CAS: 461432-26-8), ụdị ọrịa shuga II.

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, Cardboard Drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

1

Ajụjụ:

Ngwa:

A na-eji 4-Bromo-1-Chloro-2- (4-Ethoxybenzyl) benzene (CAS: 461432-23-5) dị ka etiti na njikọ nke Dapagliflozin (CAS: 461432-26-8).Dapagliflozin bụ onye na - egbochi akụrụ sodium dabere na glucose cotransporter 2 (SGLT2) maka ọgwụgwọ ụdị ọrịa shuga 2.Dapagliflozin bụ ọgwụ mgbochi ọrịa shuga ọhụrụ nke Bristol-Myers Squibb na AstraZeneca mebere, nke European Medicine Agency (EMA) kwadoro ya na Nọvemba 12, 2012. Na Jenụwarị 8, 2014, US Food and Drug Administration (FDA) akwadoro ya. maka iji ya na ọgwụgwọ ụdị ọrịa shuga II.

Dee ozi gị ebe a ziga anyị ya